Cassava Sciences Inc vs Hims and Hers Health Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Hims and Hers Health Inc trades at $30.61 (market cap $7.12B). The key difference: Hims and Hers Health Inc is far larger — about 149.1× Cassava Sciences Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | HIMS | |
|---|---|---|
Market Cap | $47.75M | $7.12B |
Sector | Health | Health |
52-Week High | $4.64 | $62.76 |
52-Week Low | $0.87 | $14.52 |
Enterprise Value | -$34.93M | $7.82B |
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →